Massachusetts Financial Services Co. MA lowered its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,418,098 shares of the company's stock after selling 100,825 shares during the period. Massachusetts Financial Services Co. MA owned about 1.42% of Option Care Health worth $56,100,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. grew its position in Option Care Health by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after acquiring an additional 344,875 shares during the last quarter. Graypoint LLC acquired a new position in shares of Option Care Health in the fourth quarter valued at approximately $1,161,000. Charles Schwab Investment Management Inc. raised its holdings in Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares during the last quarter. Global Alpha Capital Management Ltd. increased its position in Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after acquiring an additional 18,992 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Option Care Health during the fourth quarter valued at $327,000. 98.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
OPCH has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.
View Our Latest Analysis on OPCH
Option Care Health Stock Performance
Shares of Option Care Health stock traded down $0.37 during trading hours on Thursday, hitting $33.19. 382,191 shares of the company's stock traded hands, compared to its average volume of 1,748,509. The stock has a market capitalization of $5.45 billion, a price-to-earnings ratio of 27.79, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a fifty day simple moving average of $33.17 and a 200-day simple moving average of $28.58.
Insider Activity at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by company insiders.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
